BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 16403255)

  • 21. Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigation.
    Sánchez ML; Almeida J; Vidriales B; López-Berges MC; García-Marcos MA; Moro MJ; Corrales A; Calmuntia MJ; San Miguel JF; Orfao A
    Leukemia; 2002 Aug; 16(8):1460-9. PubMed ID: 12145686
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The knowledge on the 3rd type hematogones could contribute to more precise detection of small numbers of precursor B-acute lymphoblastic leukemia.
    Babusíková O; Zelezníková T; Mlcáková A; Kusenda J; Stevulová L
    Neoplasma; 2005; 52(6):502-9. PubMed ID: 16284697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antigen Expression on Blast Cells and Hematological Parameters at Presentation in Acute Lymphoblastic Leukemia Patients.
    Naeem S; Bukhari MH
    J Coll Physicians Surg Pak; 2015 Jun; 25(6):407-11. PubMed ID: 26100991
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Analysis of immunophenotypes of acute lymphoblastic leukemia by three color flow cytometry].
    Qiu Y; Wang G; Liu YJ; Shan LJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):442-4. PubMed ID: 19379584
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A; Adib M; Mokarian F; Tebianian M; Nassiri R
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Lineage assignment in acute leukemia: confrontation between cytology and immunophenotyping].
    Ben Salah N; El Borgi W; Chelbi A; Ben Lakhal F; Gouider E; Aounallah Skhiri H; Hafsia R
    Pathol Biol (Paris); 2014 Dec; 62(6):345-7. PubMed ID: 25194892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunophenotypic changes between diagnosis and relapse in childhood acute lymphoblastic leukemia.
    van Wering ER; Beishuizen A; Roeffen ET; van der Linden-Schrever BE; Verhoeven MA; Hählen K; Hooijkaas H; van Dongen JJ
    Leukemia; 1995 Sep; 9(9):1523-33. PubMed ID: 7658722
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic utility of the B-cell lineage markers CD20, CD79a, PAX5, and CD19 in paraffin-embedded tissues from lymphoid neoplasms.
    Adams H; Liebisch P; Schmid P; Dirnhofer S; Tzankov A
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):96-101. PubMed ID: 18838917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low level CD20 expression on T cell malignancies.
    Warzynski MJ; Graham DM; Axtell RA; Zakem MH; Rotman RK
    Cytometry; 1994 Jun; 18(2):88-92. PubMed ID: 7523045
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flow cytometric study of potential target antigens (CD19, CD20, CD22, CD33) for antibody-based immunotherapy in acute lymphoblastic leukemia: analysis of 552 cases.
    Raponi S; De Propris MS; Intoppa S; Milani ML; Vitale A; Elia L; Perbellini O; Pizzolo G; Foá R; Guarini A
    Leuk Lymphoma; 2011 Jun; 52(6):1098-107. PubMed ID: 21348573
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
    Janossy G; Coustan-Smith E; Campana D
    Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD34+CD38+CD19+ as well as CD34+CD38-CD19+ cells are leukemia-initiating cells with self-renewal capacity in human B-precursor ALL.
    Kong Y; Yoshida S; Saito Y; Doi T; Nagatoshi Y; Fukata M; Saito N; Yang SM; Iwamoto C; Okamura J; Liu KY; Huang XJ; Lu DP; Shultz LD; Harada M; Ishikawa F
    Leukemia; 2008 Jun; 22(6):1207-13. PubMed ID: 18418410
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
    Naghashpour M; Lancet J; Moscinski L; Zhang L
    Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunophenotyping and its clinical significance in childhood acute lymphoblastic leukemia].
    Zhang YD; Tan LN; Hu Q; Wei HY; Zhang XL; Xiong H
    Zhongguo Dang Dai Er Ke Za Zhi; 2012 Mar; 14(3):188-91. PubMed ID: 22433405
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differentiation of acute myeloid leukemia from B- and T-lineage acute lymphoid leukemias by real-time quantitative reverse transcription-PCR of lineage marker mRNAs.
    Saussoy P; Vaerman JL; Straetmans N; Deneys V; Cornu G; Ferrant A; Latinne D
    Clin Chem; 2004 Jul; 50(7):1165-73. PubMed ID: 15229149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant expression of B203.13 antigen in acute lymphoid leukemia of B-cell origin.
    Gobbi G; Mirandola P; Malinverno C; Sponzilli I; Carubbi C; Ricci F; Binazzi R; Basso G; Giuliani-Piccari G; Ramazzotti G; Pasquantonio G; Cocco L; Vitale M
    Int J Oncol; 2008 Aug; 33(2):371-4. PubMed ID: 18636158
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoreactive, cytotoxic T lymphocytes specific for peptides derived from normal B-cell differentiation antigens in healthy individuals and patients with B-cell malignancies.
    Grube M; Rezvani K; Wiestner A; Fujiwara H; Sconocchia G; Melenhorst JJ; Hensel N; Marti GE; Kwak LW; Wilson W; Barrett JA
    Clin Cancer Res; 2004 Feb; 10(3):1047-56. PubMed ID: 14871984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD19-negative B-lineage acute lymphoblastic leukemia: A diagnostic and therapeutic challenge.
    Bansal S; Sharma U; Jain A; Sharma R; Yagnik B
    Indian J Pathol Microbiol; 2017; 60(4):596-598. PubMed ID: 29323085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of lineage markers using real-time quantitative polymerase chain reaction (RT-qPCR) in normal and in leukemia bone marrow.
    Saussoy P; Vaerman JL; Druez V; Deneys V; Straetmans N; Cornu G; Ferrant A; Latinne D
    Clin Chem Lab Med; 2009; 47(4):419-26. PubMed ID: 19327122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Flow cytometric analysis of cerebrospinal fluid in the diagnosis of central nervous system leukemia].
    Jiang NG; Zhu HL; Zeng TT; Su J; Zhang Y; Jia YQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2010 Jul; 41(4):664-8. PubMed ID: 20848792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.